German Flag

Patient Referral

For HCPs / Patient Referral

Treatment with CHEMOSAT has been shown to slow down and, in some cases, halt the progression of hepatic tumours in patients with metastatic uveal melanoma.

Recent UK guidelines and German S3 guidelines have recommended the use of liver directed therapy. 1,2

Delcath have a number of expert CHEMOSAT centres located throughout Europe. Referring a patient is easy, just follow the instructions below.

Download the Referral Form

Contact a CHEMOSAT referral expert

Referral Pathway  •  Unresectable Hepatic Dominant Uveal Melanoma*3-6

In line with UK & German S3 guidelines, patients presenting with hepatic dominant disease where re-section is not suitable should be considered for liver-directed therapy.

01

Assess Eligibility 7

02/A

Download and
complete the patient referral form

02

Referring
Oncologist
Clinical Assessment

02/B

Identify referral site in consultation with patient

03

Refer to
CHEMOSAT Centre

04

Assessment by
Expert CHEMOSAT
Team

05

CHEMOSAT Treatment every 6-8 weeks

06

Post Treatment
Assessment

*For illustrative purposes only, tests and timelines may vary depending on the hospital and individual clinical needs. Subject to individual centre experience.

Patient Timelines and Touchpoints**7

STAGE 1

REFERRAL

Location:
CHEMOSAT Centre / Local Oncology Unit

4 weeks prior to treatment:
  • Blood tests
  • MRI liver
  • MRI brain
  • CT of chest and abdomen and pelvis
STAGE 2

ASSESSMENT

Location:
CHEMOSAT Centre

1 week prior to treatment:
  • Blood tests
  • Overall fitness ECG
  • Angiogram
  • Embolisation (when required)
STAGE 3

TREATMENT

Location:
CHEMOSAT Centre

CHEMOSAT (every 6-8 weeks)

RE-ASSESSMENT

Location:
CHEMOSAT Centre / Local Oncology Unit / GP

FOLLOW UP

Location:
CHEMOSAT Centre / Local Oncology Unit / GP

** Tests and timelines may vary depending on hospital and individual clinical needs. Subject to individual centre experience.